Search Within

Jose T Baselga

  1. "Lillian Smyth"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (10)
Groups
  1. Breast Medicine Service (24)
  2. Department of Medicine (24)
  3. Solid Tumor Oncology Division (24)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  5. GSK Faculty (16)
  6. Human Oncology and Pathogenesis Program (16)

More Groups

People
  1. Lillian Smyth (24)
  2. Larry Norton (15)
  3. Clifford Hudis (13)
  4. Chau Dang (12)
  5. Sarat Chandarlapaty (12)
  6. David Hyman (10)

More People

Years
  1. 2021 (2)
  2. 2020 (3)
  3. 2018 (4)
  4. 2017 (5)
  5. 2016 (8)
  6. 2015 (2)
Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (5)
  3. Annals of Oncology (2)
  4. Breast Cancer Research and Treatment (1)
  5. Cancer Cell (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (7)
  3. Nature Publishing Group (3)
  4. Oxford University Press (3)
  5. Cell Press (1)
  6. Nature Research (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression
    Journal Article

    Piscuoglio, S.; Ng, C. K. Y.; Murray, M.; Burke, K. A.; Edelweiss, M.; Geyer, F. C.; Macedo, G. S.; Inagaki, A.; Papanastasiou, A. D.; Martelotto, L. G.; more...
    Journal of Pathology (2016)

    Fulltext@MSK | Save
  • TERT hotspot promoter mutations and TERT gene amplification in phyllodes tumors of the breast
    Meeting Abstract

    Reis, J. S.; Piscuoglio, S.; Ng, C. K. Y.; Murray, M.; Burke, K.; Edelweiss, M.; Macedo, G. S.; Geyer, F. C.; Inagaki, A.; Papanastasiou, A. D.; more...
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
    Meeting Abstract

    Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save